Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 20/20 | 1.00 |
| ▸ | PGR | P06401 | 5/20 | 0.72 |
| ▸ | AR | P10275 | 2/20 | 0.65 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6291553 | 1.00 | NR3C1 (1.00) | NR3C1PGRARNR3C2 | |
| SCHEMBL4175050 | 1.00 | NR3C1 (1.00) | NR3C1PGRARNR3C2 | |
| SCHEMBL4174539 | 0.95 | NR3C1 (1.00) | NR3C1PGRARNR3C2 | |
| SCHEMBL6294352 | 0.95 | NR3C1 (1.00) | NR3C1PGRARNR3C2 | |
| SCHEMBL4178828 | 0.95 | NR3C1 (1.00) | NR3C1PGRARNR3C2 | |
| SCHEMBL4182458 | 0.86 | NR3C1 (0.92) | NR3C1PGRARNR3C2 | |
| SCHEMBL4183187 | 0.86 | NR3C1 (0.78) | NR3C1PGRARNR3C2 | |
| SCHEMBL4179953 | 0.85 | NR3C1 (0.82) | NR3C1PGRARNR3C2 | |
| SCHEMBL4172419 | 0.85 | NR3C1 (1.00) | NR3C1PGRARNR3C2 | |
| SCHEMBL4182424 | 0.84 | NR3C1 (0.81) | NR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1303498-A1 | SUBSTITUTED 2-AMINO-1,3,5-TRIAZINES, AND THE USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | Bayer CropScience GmbH (DE) | 2003-04-23 | — | — | EP | claimed |
| US-20030073703-A1 | Glucocortiocoid-selective antinflammatory agents | ABBOTT LABORATORIES AND LIGAND PHARMACEUTICALS INCORPORATED | 2003-04-17 | — | — | US | claimed |
| US-6506766-B1 | A pharmaceutical composition for use in treating inflammation, immune, autoimmune, and inflammatory diseases in a mammal by selectively modulating the activation, repression, agonism, and antagonism effects of the mammal's glucocorticoid | ABBOTT LABORATORIES | 2003-01-14 | — | — | US | claimed |
| EP-1053239-B1 | GLUCOCORTICOID-SELECTIVE ANTI-INFLAMMATORY AGENTS | ABBOTT LAB (US) | 2003-01-08 | — | — | EP | claimed |
| JP-2002540104-A | — | — | 2002-11-26 | — | — | JP | claimed |
| WO-2002092580-A2 | 2,4-DIAMINO-1,3,5-TRIAZINES, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | BAYER CROPSCIENCE GMBH (DE) | 2002-11-21 | — | — | WO | claimed |
| WO-2002006251-A1 | SUBSTITUTED 2-AMINO-1,3,5-TRIAZINES, AND THE USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | BAYER CROPSCIENCE GMBH (DE) | 2002-01-24 | — | — | WO | claimed |
| EP-1165563-A1 | BICYCLIC HETEROCYCLES, METHOD FOR PRODUCING THEM AND THEIR USE AS HERBICIDES AND PHARMACEUTICAL AGENTS | Aventis CropScience GmbH (DE) | 2002-01-02 | — | — | EP | claimed |
| EP-1163229-A1 | 2,4-DIAMINO-1,3,5-TRIAZINES, METHOD FOR PRODUCING THEM AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS | Aventis CropScience GmbH (DE) | 2001-12-19 | — | — | EP | claimed |
| WO-2000056734-A1 | BICYCLIC HETEROCYCLES, METHOD FOR PRODUCING THEM AND THEIR USE AS HERBICIDES AND PHARMACEUTICAL AGENTS | AVENTIS CROPSCIENCE GMBH (DE) | 2000-09-28 | — | — | WO | claimed |
| WO-2000056722-A1 | 2,4-DIAMINO-1,3,5-TRIAZINES, METHOD FOR PRODUCING THEM AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS | AVENTIS CROPSCIENCE GMBH (DE) | 2000-09-28 | — | — | WO | claimed |
| US-20090227571-A1 | Androgen Receptor Modulator Compounds and Methods | LIGAND PHARMACEUTICALS INCORPORATED | 2009-09-10 | — | — | US | disclosed |
| EP-1303498-A1 | SUBSTITUTED 2-AMINO-1,3,5-TRIAZINES, AND THE USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | Bayer CropScience GmbH (DE) | 2003-04-23 | — | — | EP | disclosed |
| US-6506766-B1 | A pharmaceutical composition for use in treating inflammation, immune, autoimmune, and inflammatory diseases in a mammal by selectively modulating the activation, repression, agonism, and antagonism effects of the mammal's glucocorticoid | ABBOTT LABORATORIES | 2003-01-14 | — | — | US | disclosed |
| WO-2002092580-A2 | 2,4-DIAMINO-1,3,5-TRIAZINES, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | BAYER CROPSCIENCE GMBH (DE) | 2002-11-21 | — | — | WO | disclosed |
| WO-2002006251-A1 | SUBSTITUTED 2-AMINO-1,3,5-TRIAZINES, AND THE USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | BAYER CROPSCIENCE GMBH (DE) | 2002-01-24 | — | — | WO | disclosed |
| EP-1163229-A1 | 2,4-DIAMINO-1,3,5-TRIAZINES, METHOD FOR PRODUCING THEM AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS | Aventis CropScience GmbH (DE) | 2001-12-19 | — | — | EP | disclosed |
| WO-2000056722-A1 | 2,4-DIAMINO-1,3,5-TRIAZINES, METHOD FOR PRODUCING THEM AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS | AVENTIS CROPSCIENCE GMBH (DE) | 2000-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227571-A1 | Androgen Receptor Modulator Compounds and Methods | AR, NR5A1, ESRRA | NR3C1 21/4885PGR 44/4885AR 1/4885 |
| US-20030073703-A1 | Glucocortiocoid-selective antinflammatory agents | NR3C1, GPR119, MC2R | NR3C1 1/4885PGR 2562/4885AR 1816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.